Protalix Biotherapeutics Inc Financial Flexibility Index
Protalix Biotherapeutics Inc financial flexibility index. Protalix Biotherapeutics Inc (PLX) has a Financial Flexibility Index of 0.10x as of December 2025. Free cash flow of $3.27 Million (operating CF $2.03 Million minus capex $1.24 Million) represents 0% of total liabilities ($34.12 Million). See PLX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Protalix Biotherapeutics Inc (1996–2025)
Financial flexibility index of Protalix Biotherapeutics Inc from 1996 to 2025. Historical Financial Flexibility Index trend for Protalix Biotherapeutics Inc across 30 annual periods. Check earnings quality score of Protalix Biotherapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Protalix Biotherapeutics Inc Financial Flexibility Index by Year (1996–2025)
Protalix Biotherapeutics Inc financial flexibility index by year from 1996 to 2025. Year-by-year free cash flow to debt coverage for Protalix Biotherapeutics Inc. For the full cash flow conversion analysis, see Protalix Biotherapeutics Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.30x | $-10.36 Million | $-11.99 Million | $34.12 Million | ▼ -192.1% |
| 2024 | 0.33x | $9.96 Million | $8.67 Million | $30.21 Million | ▲ +10020.3% |
| 2023 | 0.00x | $-169.00K | $-1.32 Million | $50.87 Million | ▲ +99.1% |
| 2022 | -0.37x | $-24.37 Million | $-25.00 Million | $66.43 Million | ▼ -231.3% |
| 2021 | -0.11x | $-8.83 Million | $-10.29 Million | $79.70 Million | ▲ +58.7% |
| 2020 | -0.27x | $-25.45 Million | $-26.11 Million | $94.97 Million | ▼ -65.6% |
| 2019 | -0.16x | $-18.73 Million | $-19.36 Million | $115.71 Million | ▼ -161.6% |
| 2018 | -0.06x | $-7.06 Million | $-7.74 Million | $114.01 Million | ▲ +29.0% |
| 2017 | -0.09x | $-9.02 Million | $-9.99 Million | $103.51 Million | ▲ +74.3% |
| 2016 | -0.34x | $-31.25 Million | $-32.10 Million | $92.20 Million | ▼ -22.9% |
| 2015 | -0.28x | $-23.82 Million | $-24.28 Million | $86.38 Million | ▼ -29.7% |
| 2014 | -0.21x | $-28.50 Million | $-29.28 Million | $134.07 Million | ▼ -3.7% |
| 2013 | -0.21x | $-28.76 Million | $-30.65 Million | $140.28 Million | ▼ -722.7% |
| 2012 | 0.03x | $2.70 Million | $635.00K | $82.08 Million | ▲ +114.4% |
| 2011 | -0.23x | $-17.86 Million | $-23.57 Million | $77.88 Million | ▲ +43.0% |
| 2010 | -0.40x | $-30.61 Million | $-38.46 Million | $76.05 Million | ▼ -165.8% |
| 2009 | 0.61x | $50.65 Million | $44.45 Million | $82.79 Million | ▲ +131.3% |
| 2008 | -1.96x | $-12.64 Million | $-16.02 Million | $6.46 Million | ▼ -7.3% |
| 2007 | -1.82x | $-8.11 Million | $-10.45 Million | $4.45 Million | ▼ -16.0% |
| 2006 | -1.57x | $-4.25 Million | $-5.09 Million | $2.70 Million | ▼ -58.1% |
| 2005 | -0.99x | $-72.47K | $-72.47K | $72.93K | ▲ +58.3% |
| 2004 | -2.39x | $-168.12K | $-168.12K | $70.47K | ▼ -37.6% |
| 2003 | -1.73x | $-136.68K | $-136.68K | $78.82K | ▲ +6.5% |
| 2002 | -1.85x | $-146.59K | $-146.59K | $79.07K | ▲ +81.9% |
| 2001 | -10.22x | $-789.43K | $-789.43K | $77.28K | ▼ -10683.7% |
| 2000 | -0.09x | $-53.11K | $-53.11K | $560.61K | ▲ +96.8% |
| 1999 | -3.00x | $-1.38 Million | $-1.41 Million | $459.36K | ▼ -453.1% |
| 1998 | -0.54x | $-769.54K | $-909.52K | $1.42 Million | ▼ -1534.4% |
| 1997 | -0.03x | $-247.92K | $-247.92K | $7.47 Million | ▼ -500.7% |
| 1996 | -0.01x | $-40.57K | $-40.57K | $7.34 Million | — |